Publications

Shaw J, Hsu H, Tu H, Chia V, Aggarwal S, Carrigan G, Kelsh MA. Immortal time bias impacts time-to-time event outcomes in cohort with genomic testing. Abstract 6F-03, International Society for Pharmacoepidemiology (ISPE) 41^st Annual Meeting, Washington, DC, August 2025.

Righter R, Yale K, Stewart C, Marshall L, Fairbanks H. Methods in qualitative data analysis to progress community health equity. Abstract 3993/Poster EP02-18, International Society of Exposure Science and International Society for Environmental Epidemiology (ISES/ISEE) Joint Annual Meeting, Atlanta, GA, August 2025.

Rish W, Verwiel A. Importance of epidemiology and visualization to integrate non-chemical stressors into cumulative impact assessment for vulnerable communities. Abstract 568/Poster P47-17, International Society of Exposure Science and International Society for Environmental Epidemiology (ISES/ISEE) Joint Annual Meeting, Atlanta, GA, August 2025.

East A, Wheeler M, Kennedy S. Artificial intelligence application to critical appraisal of published literature: A case example using the Criteria for Reporting and Evaluating Ecotoxicity Data (CRED) evaluation method. Poster presentation, Health and Environmental Sciences Institute (HESI) Biannual Meeting, Washington, DC, June 2025.

Price M, Suh M, Pastula S, Kruchko C, Ostrom Q. Pediatric low-grade glioma (pLGG) incidence in the United States from 2015 through 2019. Abstract LGG-04, Society for NeuroOncology (SNO) Pediatric Neuro-Oncology Conference, San Diego, CA, May 2025.

Wikoff D. An introduction to evidence integration. Workshop Session, Abstract 1333, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Wikoff D, Fitch S, Vincent M, Southall MD, Atillasoy E, Weinstein RD, Ejaz SD, Rhoden JD, Choksi N. Biological plausibility assessment of acetaminophen and occurrence of developmental neurological outcomes in humans. Abstract 4768, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025. (Honored as one of the Risk Assessment Specialty Section’s Top 10 Abstracts).

Vincent M. The critical role of biological plausibility in evidence integration. Abstract 1336, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Thompson CM, Heintz MM, Cullen JM, Haws LC. Evaluation of the chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate (HFPO-DA) in mice. Abstract 4700, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Sweeney LM, Coyle JP, Covington TR, Sterner TR, Clewell RA. Rapid dosimetry in a tiered chemical screening process for military personnel-toxicokinetic considerations for a case study with in vitro neurotoxicity. Abstract 3495, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Stemer TR, Covington TR, Cowan DW, Coyle JP, Gearhart JM, LaLonde TJ, Ring CL, Sweeney LM, Wambaugh JF, Wooten AT, Bang AG, Clewell RA. Rapid risk assessment of potential neurotoxicants using non-animal test methods. Abstract 4842, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Rogers JM, Heintz MM, Haws LC. Reproduction/developmental toxicity screen and extended one generation reproductive toxicity study of decahydronaphthalene in Sprague Dawley rats. Abstract 3864, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Rivera BN, Lea IA, Fitch S, Choksi N, Franzen A, Bus J, Rushton EK, Borghoff SJ. Systematic evaluation of the evidence base on ethyl tert-butyl ether and tert-butyl alcohol for carcinogenic potential in humans: Low concern based on animal cancer studies and mechanistic data. Abstract 4697, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Proctor D, Thompson C. Why oral cavity tumors should not be the basis of the hexavalent chromium oral cancer slope factor-weight of evidence review. Abstract 3136, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025. (Honored as one of the Risk Assessment Specialty Section’s Top 10 Abstracts).

Price S, Chen K, Finley B. Estimating infant blood levels from baby food consumption: A biokinetic model analysis. Abstract 4080, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Mihalchik A. Strategies to evaluate over-the-counter drug degradants. Abstract 1252, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Lea IA, Holt J, Bunnage E, Long M, Chew R, Bell S, Edwards S, Sayre R, Vliet SM, Lynn SG, Kristan MJ. Integrated computational approaches in systematic evidence mapping: Bridging human expertise and machine learning for advanced toxicological assessments. Abstract 3409, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Klaren W. Targeted state of the science scoping review for incorporating stress within experimental models of chemical toxicity. Abstract 1260, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Klaren W. Incorporating stress as a variable into toxicological testing: Advancing our understanding of cumulative impacts. Abstract 1259, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025.

Heintz MM, Buerger AN, Haws LC, East AW, Cullen JM, Thompson CM. Comparison of phenotypic and transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mice. Abstract 3972, Society of Toxicology 64^th Annual Meeting, Orlando, FL, March 2025